In this pilot study, we aimed to investigate the immunomodulatory effects of cryoablation on blood and surgical samples, focusing on CD3+, CD4+, and CD8+ T cells, as well as key subsets involved in anti-tumor activity (CD137+) and immune suppression (Tregs). This evidence concerns the gene TNFRSF9 and neoplasm.